Science Explorer Interactive view Map
Funder · Shizuoka · Japan

Shizuoka Cancer Center

In research, Shizuoka Cancer Center stands highest in Medicine (#2,582 of 10,443 worldwide), Health Sciences (#3,670 of 11,982 worldwide) and Surgery (#1,099 of 1,816 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology, Pulmonary and Respiratory Medicine and Surgery — Oncology is 18.0× its share of world research.

scchr.jpROR OpenAlex
World rank, 2022–2025
#12,556
of 28,054 · #17,097 all time
Rank in Japan
#327
of 1,070
Research works
2.7k
◆ 1% vs 2013–17
Citations
41k
15.1 per fractional work
Top-10% rate
9.0%
record average 16.5%
Open access
47%
world 28%

What is Shizuoka Cancer Center known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #2,582 of 10,443 9.1%504 #3902
Health SciencesDomain #3,670 of 11,982 9.1%510 #5328
SurgerySubfield #1,099 of 1,816 11.0%109 #1460
Pulmonary and Respiratory MedicineSubfield #796 of 1,144 9.4%114 #895
OncologySubfield #633 of 772 9.0%116 #902

Each strip is that field’s whole ranked pool, with the notch where Shizuoka Cancer Center sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Medicine#3,902 #2,582
  2. Health Sciences#5,328 #3,670
  3. Surgery#1,460 #1,099
  4. Pulmonary and Respiratory Medicine#895 #796
  5. Oncology#902 #633
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Shizuoka Cancer Center specialise in?

Where its research is concentrated relative to its size: Oncology takes 18.0× the share of its output that it takes of world research.

  1. OncologySubfield · 116.0 works18×
  2. Pulmonary and Respiratory MedicineSubfield · 113.6 works13×
  3. SurgerySubfield · 108.7 works8.1×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.01× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.27× its world share, 39 worksBiochemistry, Geneti…Immunology and Microbiology: 1.13× its world share, 6 worksImmunology and Micro…Neuroscience: 0.19× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 1.07× its world share, 2 worksPharmacology, Toxico…Chemistry: 0.08× its world share, 1 worksChemistryComputer Science: 0.04× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.01× its world share, 0 worksEarth and Planetary …Engineering: 0.02× its world share, 2 worksEngineeringEnvironmental Science: 0.01× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.04× its world share, 1 worksMaterials ScienceMathematics: 0.19× its world share, 1 worksMathematicsPhysics and Astronomy: 0.26× its world share, 3 worksPhysics and AstronomyDentistry: 0.48× its world share, 1 worksDentistryHealth Professions: 0.22× its world share, 3 worksHealth ProfessionsMedicine: 4.58× its world share, 504 worksMedicineNursing: 0.37× its world share, 1 worksNursingVeterinary: 0.07× its world share, 0 worksVeterinaryDecision Sciences: 0.01× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.10× its world share, 1 worksEconomics, Econometr…Psychology: 0.08× its world share, 2 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.6×. Every wedge is a field page.

Who are the top researchers at Shizuoka Cancer Center?

Ranked on the composite score, Kentaro Yamazaki, Masaki Tanaka and Haruhiko Kondo lead among researchers whose main affiliation is Shizuoka Cancer Center.

  1. 1 Kentaro Yamazaki Japan · #83,472 worldwide 372 citations · 91 works
  2. 2 Masaki Tanaka Japan · #87,340 worldwide 275 citations · 33 works
  3. 3 Haruhiko Kondo Japan · #116,988 worldwide 195 citations · 46 works
  4. 4 Katsuhiko Uesaka Japan · #151,762 worldwide 238 citations · 100 works
  5. 5 Tadakazu Shimoda Japan · #156,337 worldwide 104 citations · 35 works
  6. 6 Takeshi Aramaki Japan · #229,860 worldwide 75 citations · 21 works
  7. 7 Hiroshi Fuji Japan · #263,163 worldwide 75 citations · 25 works
  8. 8 Sunao Tamai Japan · #309,656 worldwide 79 citations · 17 works
  9. 9 Yoshio Kiyohara Japan · #349,075 worldwide 50 citations · 28 works
  10. 10 Yusuke Yamamoto Japan · #370,162 worldwide 105 citations · 57 works
All ranked researchers at Shizuoka Cancer Center

Which keywords describe research at Shizuoka Cancer Center?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Immunotherapy, Neoadjuvant Therapy, Prognostic Factors, Survival Analysis, Endoscopic Resection and Molecular Characterization.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy130▲ 32×23 topics
  2. Clinical Practice Guidelines70▲ 23×11 topics
  3. Epidemiology64▲ 2.8×50 topics
  4. Immunotherapy60▲ 15×17 topics
  5. Neoadjuvant Therapy60▲ 44×5 topics
  6. Prognostic Factors58▲ 23×14 topics
  7. Survival Analysis50▲ 32×7 topics
  8. Endoscopic Resection48▲ 85×2 topics
  9. Molecular Characterization48▲ 48×5 topics
  10. Adjuvant Therapy48▲ 65×2 topics
  11. Tumor Microenvironment44▲ 17×8 topics
  12. Surgical Management42▲ 18×16 topics
  13. Gastric Cancer38▲ 59×3 topics
  14. Targeted Therapy37▲ 29×4 topics
  15. Radiotherapy37▲ 17×13 topics
  16. Neoadjuvant Chemotherapy36▲ 75×2 topics
  17. Cholangiocarcinoma36▲ 79×2 topics
  18. Lymph Node Dissection33▲ 98×1 topic
  19. Metastatic Gastric Cancer33▲ 98×1 topic
  20. Clinical Trials31▲ 8.1×9 topics
  21. Pancreatic Cancer28▲ 45×3 topics
  22. Preoperative Chemoradiotherapy28▲ 62×2 topics
  23. Gemcitabine27▲ 66×1 topic
  24. Surgical Complications27▲ 59×1 topic
  25. Treatment25▲ 3.6×28 topics
  26. Tumor Markers24▲ 51×2 topics
  27. Adjuvant Chemotherapy24▲ 59×2 topics
  28. Metastasis23▲ 12×9 topics
  29. Diagnosis23▲ 4.4×21 topics
  30. Chemoradiation22▲ 59×2 topics
  31. Molecular Pathology21▲ 35×3 topics
  32. Biliary Tract Cancer21▲ 100×1 topic
  33. Intrahepatic Cholangiocarcinoma21▲ 100×1 topic
  34. Survival19▲ 25×4 topics
  35. Breast Cancer19▲ 14×10 topics
  36. PET Imaging18▲ 19×4 topics
  37. Prognosis18▲ 9.6×6 topics
  38. Surgery17▲ 8.7×10 topics
  39. Cetuximab17▲ 36×2 topics
  40. Treatment Guidelines17▲ 14×3 topics

Which research topics does Shizuoka Cancer Center publish most on?

By volume in 2022–2025: Gastric Cancer Management and Outcomes, Pancreatic and Hepatic Oncology Research, Cholangiocarcinoma and Gallbladder Cancer Studies and Lung Cancer Treatments and Mutations.

Gastric Cancer Management and Outcomes: 33 fractional worksPancreatic and Hepatic Oncology Research: 27 fractional worksCholangiocarcinoma and G…21Cholangiocarcinoma and Gallbladder Cancer Studies: 21 fractional worksLung Cancer Treatments a…16Lung Cancer Treatments and Mutations: 16 fractional worksEsophageal Cancer Research and Treatment: 15 fractional worksGallbladder and Bile Duct Disorders: 14 fractional worksLung Cancer Diagnosis an…14Lung Cancer Diagnosis and Treatment: 14 fractional worksGastrointestinal Tumor R…14Gastrointestinal Tumor Research and Treatment: 14 fractional worksColorectal Cancer Surgic…13Colorectal Cancer Surgical Treatments: 13 fractional worksCancer Immunotherapy and…11Cancer Immunotherapy and Biomarkers: 11 fractional works
Pulmonary and Respiratory MedicineOncologySurgeryGastroenterology

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 33 works
  2. 2 Pancreatic and Hepatic Oncology Research Oncology 27 works
  3. 3 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 21 works
  4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 16 works
  5. 5 Esophageal Cancer Research and Treatment Surgery 15 works
  6. 6 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 14 works
  7. 7 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 14 works
  8. 8 Gastrointestinal Tumor Research and Treatment Gastroenterology 14 works
  9. 9 Colorectal Cancer Surgical Treatments Oncology 13 works
  10. 10 Cancer Immunotherapy and Biomarkers Oncology 11 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available46.7%not open53.3%

World: 28% of research is openly available.

with international co-authors6.9%domestic only93.1%

World: 19% is written across borders.

How has Shizuoka Cancer Center's research output changed?

Output in 2018–2022 was 1% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Shizuoka

All research institutions in Shizuoka

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.